Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Celgene Corporation News

Earnings Aren't Enough: Cramer's 'Mad Money' Recap (Friday 1/31/20)

Wall Street only has eyes for the coronavirus news, Jim Cramer says. And with the selloff likely to continue next week, he's got your defensive game plan.

Where's the Bear?: Cramer's 'Mad Money' Recap (Thursdsay 1/30/20)

Don't be too glib about recession talk, says Jim Cramer. Instead, be informed.

Bristol-Myers Closes $74 Billion Celgene Takeover; Shares Gain

Bristol-Myers Squibb shares edged higher Thursday after the pharmaceutical group said it has completed its $74 billion acquisition of cancer drug specialist Celgene Corp.

Bristol-Myers Squibb Slips on Poor Skin Cancer Trial Results

Bristol-Myers Squibb trades lower after the pharmaceutical giant reveals a recent trial involving one of its treatments for melanoma skin cancer did not meet its main objective.

Breaking News

Elon Musk Says Only Two Things Could Make Him Leave Tesla

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

Caesars Inches Closer to Huge Las Vegas Strip Move

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023